IP Library › Assignment 064748/0526
Patent Assignment
Reel/Frame 064748/0526

Assignment of Assignor's Interest

Recorded: 2023-08-30 Pages: 4
Assignor
BRISTOL-MYERS SQUIBB COMPANY
Executed: 2022-02-22
Assignee
IMPACT BIOMEDICINES, INC.
86 MORRIS AVENUE, SUMMIT, NEW JERSEY, 07901
Covered Properties (2)
Use of Bet Inhibitors as a Treatment for Myelofibrosis
Bet Inhibitors as a Treatment for Myelofibrosis
Application: 17/680,569 →
Publication: US 2022/0265617
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 30, 2023
From: CELGENE CORPORATION
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 064748/0381 →
Assignment of Assignor's Interest Aug 30, 2023
From: COKER, SHODEINDE; LIU, YU
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 064748/0456 →
Assignment of Assignor's Interest Aug 30, 2023
From: ARONCHIK, IDA; BELTRAN VALENCIA, ROXXANA VALERIA; CARRANCIO ANTON, MARIA SORAYA; CHANG, HENRY H.
To: CELGENE CORPORATION
Reel/Frame 064760/0300 →